Lurasidone Hydrochloride Tablet
Product Images NDC 65862-956

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 65862-956). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Impact Of Other Drugs On Lurasidone Hydrochloride Pharmacokinetics (Lurasidone Fig1)

A horizontal dot plot chart showing the impact of various interacting drugs on the pharmacokinetics (Cmax and AUC) of Lurasidone. The x-axis represents fold change relative to Lurasidone alone, ranging from -4 to 4. The interacting drugs include Strong CYP3A4 Inhibitor Ketoconazole 400 mg/day, Moderate CYP3A4 Inhibitor Diltiazem 240 mg/day, and Strong CYP3A4 Inducer Rifampin 600 mg/day, as well as Lithium 600 mg BID. Each drug has plotted points with 90% confidence intervals indicating changes in Cmax and AUC pharmacokinetic parameters.*

FDA Label Image

Figure 2: Impact Of Lurasidone Hydrochloride On Other Drugs (Lurasidone Fig2)

A forest plot chart depicting fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, or Ctrough) of various interacting drugs relative to the interactive drug alone. The interacting drugs include Digoxin 0.25 mg, Midazolam 5 mg, Ethinyl Estradiol, Noregestromin, and Lithium 600 mg BID, categorized by P-gp substrates, CYP3A4 substrates, and oral contraceptives.*

FDA Label Image

Figure 3: Impact Of Other Patient Factors On Lurasidone Hydrochloride Pharmacokinetics (Lurasidone Fig3)

A scatter plot with error bars showing fold change and 90% confidence intervals of pharmacokinetic parameters (Cmax and AUC) for Lurasidone Hydrochloride across different patient groups. The chart compares effects of mild, moderate, and severe renal and hepatic impairment, and variations by gender and race, relative to a reference value of 1.*

FDA Label Image

Package Label-principal Display Panel (20 mg (30 Tablets Bottle))

Lurasidone Hydrochloride Tablets 20 mg label for a 30-tablet package by Aurobindo Pharma USA, Inc. The label states each film-coated tablet contains 20 mg of lurasidone hydrochloride, includes storage instructions, distributor address in New Jersey, and a barcode. The product is made in India and marked Rx only.*

FDA Label Image

Package Label-principal Display Panel (40 mg (30 Tablets Bottle))

Label for Lurasidone Hydrochloride Tablets 40 mg, a prescription drug supplied in a 30 tablet package. The label states each film-coated tablet contains 40 mg of lurasidone hydrochloride. It is distributed by Aurobindo Pharma USA, Inc. and made in India by Aurobindo Pharma Limited. Storage instructions specify 20° to 25°C (68° to 77°F). A barcode and an overprinting zone for coding are visible.*

FDA Label Image

Package Label-principal Display Panel (60 mg (30 Tablets Bottle))

Label for Lurasidone Hydrochloride Tablets 60 mg, a prescription drug product. The label indicates the tablet strength as 60 mg, with a package quantity of 30 tablets. It includes storage instructions, the distributor as Aurobindo Pharma USA, Inc., and notes the product is made in India by Aurobindo Pharma Limited. The label also features an NDC number and a barcode.*

FDA Label Image

Package Label-principal Display Panel (80 mg (30 Tablets Bottle))

Label for Lurasidone Hydrochloride Tablets, 80 mg, film-coated tablets, packaged as 30 tablets. Distributed by Aurobindo Pharma USA, Inc., made in India. The label includes storage instructions (20° to 25°C), a barcode, and a note to dispense the Medication Guide with each prescription. The label also indicates the product is prescription only.*

FDA Label Image

Package Label-principal Display Panel (120 mg (30 Tablets Bottle))

Label for Lurasidone Hydrochloride Tablets 120 mg, a prescription drug tablet by Aurobindo Pharma Limited. The label states 30 tablets per container and includes storage instructions, distributor information (Aurobindo Pharma USA, Inc.), and a barcode. The label notes the medication guide must be dispensed separately.*

FDA Label Image

Chemical Structure (Lurasidone Str)

Chemical structure diagram of Lurasidone Hydrochloride showing its molecular framework with labeled atoms and bonds, including the hydrochloride (HCl) component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.